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Abstract. Rifampin is an important drug used in the treatment of tuberculosis, and it increases the drug metabolism in human 
hepatocytes. Previous studies have shown that rifampin can indirectly influence drug deposition through the regulation of 
molecular interactions of miRNA, PXR and other genes. The potential functions of miRNAs associated with rifampin-
induced drug disposition are poorly understood. In this study, significantly differentially expressed miRNAs (SDEM) were 
extracted and used to predict the miRNA-regulated co-expression target genes (MCeTG). Additionally, a miRNA-regulated
co-expressed protein interaction network (MCePIN) was constructed for SDEM by extending from the protein interaction 
network (PIN). The functioning of the miRNAs were analyzed using GO analysis and KEGG pathway enrichment analysis. 
A total of 20 miRNAs belonging to SDEM were identified, and 632 miRNA-regulated genes were predicted. The MCePIN 
was constructed by extending from PIN, and 10 miRNAs and 33 genes that are relevant to 7 functions, including response to 
wounding, wound healing, response to drug, defense response, inflammatory response, liver development and drug 
metabolism, were discerned. The results provided by this study offer valuable insights into the effect of rifampin on miRNAs,
genes and protein levels.
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1. Introduction
Rifampin is an effective antimicrobial drug that is usually used to treat tuberculosis and other 
infections [1]. Rifampin works by inducing the drug-metabolizing enzymes and transporters [2].
Rifampin, a typical ligand of the Pregnane X receptor (PXR), has been shown to strongly stimulate 
* Address for correspondence: Wang Cong, Harbin Engineering University, 145, Nantong Street, Nangang District, Harbin, 
Heilongjiang, 150001, China. Tel.: 86-451-82519998; Fax: 86-451-82519253; E-mail: cwcy9156@163.com. 
Yunlong Liu, Harbin Engineering University, 145, Nantong Street, Nangang District, Harbin, Heilongjiang, 150001, China.
Tel.: 86-451-82569412; Fax: 86-451-82589400; E-mail:yunliu@iupui.edu.
0959-2989/15/$35.00 © 2015 – IOS Press and the authors.
DOI 10.3233/BME-151502
IOS Press
Bio-Medical Materials and Engineering 26 (2015) S1985–S1991
This article is published with Open Access and distributed under the terms of the Creative Commons Attribution and Non-Commercial License.
S1985
drugs by activating the PXR [3-5], and is also an inducer of many cytochrome P450 (p450) enzymes 
[2]. And RXR regulator mediates the gene expression including some genes of P450 [6].
MicroRNAs (miRNAs) are a class of 22nt non-coding RNAs that typically regulate protein-coding 
genes at the post-transcription level [7, 8], and are predicted to regulate more than one-third of the 
protein-genes in the human genome [9]. Rifampin-induced miRNA expression changes are correlated 
with rifampin treatment changes in PXR and P450 [6, 10-12]. MiRNA can indirectly influence 
rifampin-induced drug deposition through gene regulation [11, 13-15]. Proteins are synthesized from 
mRNA templates through a highly conserved process, many studies have reported that the functions of 
miRNAs can be understood by analyzing miRNAs-regulated mRNA-related PIN [16-18].
In this study, miRNA and mRNA expression profiles were combined to better understand the 
functions of rifampin-regulated miRNAs and their potential molecular mechanisms within human 
hepatocytes. Following this initial analysis, the target genes of each differentially expressed miRNA 
were predicted. Furthermore, MCeTG were extracted, and rifampin-induced miRNAs-regulated co-
expression PIN was constructed by integrating the PPI network. In addition, the functioning of the 
different miRNAs was analyzed by assessing the underlying MCePIN of each miRNA using 
functional enrichment analysis. The results provided by this study offer new insights into the miRNA 
and miRNA function when interacting with rifampin. 
2. Materials and methods
2.1. Data source
The mRNA expression dataset (n=12780) and miRNA expression dataset (n=334) were obtained as 
in Ramanoorthy, et al [9]. Briefly, seven hepatocyte samples from seven different human were treated 
with rifampin, and the RNA was isolated from tye samples using the miRNease kit. The expressions of 
754 miRNAs were measured using the Taqman OpenArray Human miRNA Panel. The mRNA 
expressions were obtained using EZBead preparation, Next-Gene sequencing, read quality assessment, 
sequence alignment and RNA-Seq differential expression analysis. 
2.2. Statistical analysis
Benjamini-Hochberg correction was applied to control for the false discovery rate (FDR) [19]. A p-
value was calculated for each miRNA and each gene of two groups (normal and rifampin-treated 
samples) with an unpaired, two-tailed Student’s t test.
2.3. Target gene prediction 
The miRNAs were significantly different when the p-value < 0.01. The predicted miRNA target 
genes were predicted in Targetscan [20, 21], miRanda [22] and PicTar [23] using RmiR.hsa, which 
retrieved the targets or the miRNAs in miRNA target databases for given miRNAs or genes without 
any threshold. BioMart [24] was used to convert gene Entrez ID into the gene Symbol.
2.4. Constrction of MCePIN
The Human Protein Reference Database (HPRD) [25] includes 30047 proteins and 41327 protein-
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protein interactions. The human liver protein interaction network (HLPN) is composed of 3484 
interactions among 2582 proteins relevant to human liver. The MCePIN was created through the 
integration from the proteins and interactions of the HPRD and HLPN. However, duplicates were 
excluded [26]. The cytoscape [27], version 3.0.2 software was used to generate the network.
2.5. Enrichment analysis of modules
Enrichment analysis of the biological processes and pathways of the MCePIN was processed with 
the Database for Annotation, Visualization and Integrated Discovery (DAVID), which is a tool for 
biological interpretation of genes. Functional classification of important gene pathways was carried 
out using the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). 
3. Results and discussions
3.1. MCePIN
MCePIN was constructed using the significantly different expressed miRNAs, their co-expressed 
significantly different expressed target genes and the interactions between them. 
The differentially expressed miRNAs were retrieved based on a p-value (p<0.05). The upregutalted 
and downregulated miRNAs were identified using threshold (Fold Change>1) and threshold (Fold 
Change<1), respectively. There were 20 miRNAs, including 12 upregulated miRNAs and 8 
downregulated miRNAs left (Table 1).
To extract target genes of 20 miRNAs in a liberal standard, Pictar, Targetscan and miRanda 
databases were used without setting any threshold. The target genes of the 20 miRNAs were the mixed 
dataset of the results from the three databases. In this analysis, our primary focus was on the genes in 
the gene expression profile. Therefore, 6211 genes were extracted, and the negatively regulated target 
genes of each miRNA were obtained using the fold change that represents a measure of expression 
changes. As a result, 4115 co-expression genes of the 20 miRNAs were retained. From this, there were 
632 significantly differentially expressed genes, and 1187 co-expression miRNA-gene pairs were 
identified. The HPRD and HLPN were integrated by merging all the proteins and interactions, and
then removing the duplicates. The human PIN included 42521 interactions among 10210 proteins.
Table 1
Differentially expressed miRNA dataset
miRNA P-value Fold Change miRNA p-value Fold Change
upregulated upregulated
miR-886-3p 0.00017781 1.56454118 miR-660 0.02971142 1.26423062
miR-766 0.00746736 1.42202073 miR-638 0.0302057 1.67681216
miR-92a 0.01687698 1.13186208 miR-25 0.0337675 1.27581638
miR-107 0.01770697 2.18865184 miR-616 0.04464574 1.33365615
miR-30d# 0.01945112 1.15621932 miR-576-3p 0.04528093 2.19157158
miR-335 0.02415006 1.33006108 miR-218 0.04993545 1.9012223
Downregulated
miR-186 0.00177975 0.83561977 miR-320 0.03756323 0.77870999
miR-361 0.01111667 0.7086572 miR-202 0.03960494 0.59880068
miR-95 0.02185477 0.63201986 miR-200b# 0.04256355 0.60539667
miR-345 0.0239214 0.81506025 let-7g 0.04347655 0.84016356
J. Li et al. / Integrative network analysis of rifampin-regulated miRNAs and their functions in human hepatocytes S1987
Based on the interactions in the human PIN, the relationships of the 632 proteins were established. 
Specifically, the miRNA-regulated PINs were extended by choosing the first level proteins nodes of 
genes. So, the MCePIN was constructed from 11219 interactions among 20 miRNAs and 632 proteins.
Among the 1187 co-expression miRNA-gene pairs, miR-660 negatively regulated the most genes 
(136), and miR-886 negatively regulated the least genes (12). In this analysis, the rifampin-associated 
genes were further to reveal potential miRNA-related PINs and the functions of miRNAs.
3.2. Enrichment analysis of miRNA functions
The biological classification tool DAVID, based on GO and KEGG, was used to describe the 
functional classification and signal pathways of the miRNAs and MCePIN genes. Based on the 
extension of network with PIN, GO terms and KEGG keys pathways associated with drug-induced 
were excluded. Functional annotation clustering was used to extract the concerned functions, and Go 
terms and KEGG pathways that contained “drug”, “liver”, “metabolic”, “response”, “wound” and 
“stimulus” were defined as drug-related functions. The results of the enriched biological processes for 
the genes and proteins related to the rifampin are listed in Table 2.
Table 2
Enrichment analysis of miRNA-regulated genes and proteins in MCePIN
DAVID description Gene protein p-value
GO:0009611, response to wounding a stimulus indicating damage to the organism 22 186 6.0E-26
GO:0042060, wound healing restore integrity to a damaged tissue 7 85 7.7E-18
GO:0042493, response to drug a result of a drug stimulus 15 77 1.2E-13
GO:0006952, defense response response to the presence of a foreign body or 
the occurrence of an injury
19 143 4.6E-5
GO:0006954, inflammatory response The immediate defensive reaction to infection 
or injury
16 96 8.6E-4
GO:0001889, liver development The process whose specific outcome is the 
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Table 3
The rifampin-associated miRNAs and genes of MCePIN
function miRNA gene
response to wounding
miR-107, miR-186, miR-218, miR-
576-3p, miR-886-3p, miR-335, miR-
616, miR-766
AHSG, IL1RAP, IL1RN, THBS1, F8, IL10RB,
IL20RB, SGMS1, P2RX7, CD55, CXCL13, HIF1A,
RELA, IGF1, PLSCR4, SLC1A2, TPM1
wound healing Let-7g, miR-107, miR-218, miR-576-3p, miR-766, miR-886-3p HBEGF, SYT7, PLSCR4, TPM1, IGF1, F8
response to drug miR-218, miR-766, miR-886-3p, miR-660, miR-576-3p
ABAT, CAV1, SLC1A2, BCHE, CAV2, HMGCS1,
PLIN2, PPARG, P2RX7
defense response miR-576-3p, miR-335, miR-186, miR-886-3p
CD55, CXCL13, HIF1A, RELA, AHSG, IL1RAP,
IL1RN, THBS1, F8, IL10RB, IL20RB, SGMS1,
PPARG, P2RX7
inflammatory response miR-576-3p, miR-335, miR-186 CD55, CXCL13, HIF1A, RELA, AHSG, IL1RAP,IL1RN, THBS1, F8, IL10RB, IL20RB, SGMS1
liver development miR-107, miR-186 ONECUT2, ARF6, SP3, TGFBR3, CEBPA, RELA
Drug metabolism-P450 miR-107, miR-335, miR-186 ADH1B, CYP3A5
J. Li et al. / Integrative network analysis of rifampin-regulated miRNAs and their functions in human hepatocytesS1988
Response to wounding, wound healing, response to drug, defense response, inflammatory response, 
liver development and drug metabolism are the seven different functions that were identified Table 2). 
The rifampin-associated miRNAs and genes are listed in Table 3.
A total of 33 different rifampin-associated genes were identified (Table 3). Among them, P450 and 
CYP3A5 have been reported to have important roles in drug metabolism [28-30], and SP3, ARF6, 
CEBPA, RELA are responsible for liver development [31-34]. In addition, CXCL13 and RELA have 
been previously reported as inflammatory markers [35, 36].
The ten rifampin-associated miRNAs that targeted the 33 genes are listed as follow: miR-107, miR-
186, miR-218, miR-576-3p, miR-886-3p, miR-335, miR-616, miR-766, miR-218 and Let-7g. Previous 
studies have reported that rifampin induced expression change of genes and miRNAs [9, 10]. These 
results suggest that miR-107, miR-186, miR-218, miR-576-3p, miR-886-3p, miR-335, miR-616 and 
miR-766 were correlated with response to wounding via direct or indirect mechanisms through 
regulating genes. Additionally, let-7g, miR-107, miR-218, miR-576-3p, miR-799 and miR-886-3p 
were related to wound healing via induced 6 genes. Further, miR-218, miR-766, miR-886-3p, miR-
660 and miR-576-3p enriched in response to drug, and miR-107 and miR-186 were candidates for 
participating in liver development. Similarly, miR-107, miR-335 and miR-186 were suggested to be 
related to drug metabolism through the regulation of ADH1B and CYP3A5 [37].
3.3. Analysis of rifampin-associated miRNAs and negatively regulated genes
To reveal the rifampin-associated miRNAs and genes, the miRNA-genes co-expression network was 
constructed (Figure 1). 
There were 10 miRNAs that negatively regulated the 33 genes, and 62 miRNA-gene pairs in the 
network. To focus on the rifampin-associated miRNAs, miR-576-30, which controlled 11 genes, was 
designated as the most important in the network, and is suggested to participate in response to 
wounding, wound healing, response to drug, defense response and inflammatory response. The miR-
186 negatively regulated 7 genes, including CYP3A5, and it is suggested that miR-186 associated with 
the drug metabolic process. Although miR-335 did not negatively regulate CYP3A5, which is relevant
Fig. 1. Key miRNA-genes co-expression network. The yellow and grey rectangles represent the downregulated and 
upregulated miRNAs, respectively. The circles express the miRNA-regulated genes, and the regulatory relationships are 
denoted by colors, in which red and green indicate upregulated and downregulated genes, respectively. The depth of the color 
represents the size of the fold change.
J. Li et al. / Integrative network analysis of rifampin-regulated miRNAs and their functions in human hepatocytes S1989
to drug metabolism, it did negatively control ADH1B, which is also related to drug metabolism. 
The 33 genes performed the functions directly or indirectly through proteins. ADH1B, IGF1, CAV1, 
and SGMS1 had the major quantity changes, and were regulated by multiple miRNAs. CYP3A5 is an 
important gene that takes part in drug metabolism and differentially expressed. These results suggest 
that these five genes have important functions in the rifampin-induced biological process.  
4. Conclusion
To understand the rifampin-induced differentially expressed miRNAs and their functions, the 
miRNA and gene profile were integrated to identify significant differential miRNA and miRNAs 
negatively regulated genes, further to constructed MCePIN by PIN. Consequently, seven functions 
were extracted through GO analysis and KEGG pathway enrichment. Moreover, it is suggested that 
miRNAs and genes are associated with each function. As a whole, the results suggest that rifampin 
contributes to changes in the expression of multiple miRNAs. It provides evidence for an important 
regulatory function of miRNAs in the rifampin-induced biological process in human hepatocytes. 
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